Fate Therapeutics (FATE) PT Raised to $6 at BMO Capital
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.49 +2.05%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 8 | New: 13
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 8 | New: 13
Join SI Premium – FREE
BMO Capital analyst Etzer Darout raised the price target on Fate Therapeutics (NASDAQ: FATE) to $6.00 (from $5.40) while maintaining a Market Perform rating.
You May Also Be Interested In
- Calumet Specialty Products Partners (CLMT) PT Raised to $47 at UBS
- Palo Alto Networks (PANW) PT Raised to $384 at JPMorgan Ahead of Q4 Results
- Nintendo Co Ltd. (7974:JP) (NTDOY) PT Raised to JPY10,000 at Benchmark
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
